The assay titled "DRUGMATRIX: Adenosine A2A radioligand binding" utilizes the ligand AB-MECA and targets a single homologous protein. The assay is conducted using HEK293 cells and the subcellular fraction tested is the membrane. The test is conducted in vitro and focuses on measuring the binding properties of the ligand. Does the molecule exhibit a significant level of efficiency in this particular assay?